WallStreetZenWallStreetZen

NASDAQ: ELYM
Eliem Therapeutics Inc Earnings & Revenue

ELYM earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$14.5M
Current Profit Margin
0%

ELYM Return on Equity

Current Company
-13.3%
Current Industry
16.8%
Current Market
28.2%
ELYM's Return on Equity (-13.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ELYM announces earnings.

ELYM Return on Assets

Current Company
-12.9%
Current Industry
3.2%
ELYM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ELYM Return on Capital Employed

Current Company
-13.65%
Current Industry
-42.4%
ELYM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELYM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ELYM$0.00-$14.16M-$14.53MN/AN/A
CHRS$301.87M-$10.90M-$59.29M+52.09%N/A
TRVI$0.00-$33.30M-$33.57MN/AN/A
LCTX$8.00M-$22.96M-$23.66M+8.94%N/A
XBIT$0.00-$28.71M-$30.74M-100.00%N/A

Eliem Therapeutics Earnings & Revenue FAQ

What were ELYM's earnings last quarter?

On Invalid Date, Eliem Therapeutics (NASDAQ: ELYM) reported Q1 2024 earnings per share (EPS) of -$0.06, up 92.86% year over year. Total Eliem Therapeutics earnings for the quarter were -$1.70 million. In the same quarter last year, Eliem Therapeutics's earnings per share (EPS) was -$0.84.

If you're new to stock investing, here's how to buy Eliem Therapeutics stock.

What was ELYM's earnings growth in the past year?

As of Q3 2024, Eliem Therapeutics's earnings has grown year over year. Eliem Therapeutics's earnings in the past year totalled -$14.53 million.

What was ELYM's revenue last quarter?

On Invalid Date, Eliem Therapeutics (NASDAQ: ELYM) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Eliem Therapeutics's revenue was $0.00.

What was ELYM's revenue growth in the past year?

As of Q3 2024, Eliem Therapeutics's revenue has grown null year over year. Eliem Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.